Abstract
Phospholipase A2 (PLA2) is believed to play an essential role in inflammation through the release of arachidonic acid from membrane phospholipids for the production of important lipid mediators such as eicosanoids and platelet activating factor (Van den Bosch, 1980; Glaser et al, 1993). The last years it has become clear that PLA2S are a heterogeneous family of enzymes that can be classified in two classes based on their molecular weight. There is a class of low molecular weight PLA2S (14 kDa) and one of the more recently discovered high molecular mass enzymes (85 kDa). The high molecular weight PLA2, also referred to as cPLA2, is mainly located in the cytosolic fraction of cells and tissues including human platelets (Takayamo et al, 1991), rat renal mesangial cells (Gronich et al, 1988; Bonventre et al, 1990), and the human monoblast U937 cell line (Clark et al., 1990; Kramer et al, 1991). Although the enzyme has been shown to be 85 kDa by sequence and cloning (Clark et al, 1991; Sharp et al, 1991), it shows a molecular weight on SDS-PAGE of about Mr 110,000 (Leslie et al, 1988; Clark et al, 1990; Kramer et al, 1991). This enzyme preferentially hydrolyzes arachidonic acid from the sn-2-position of phospholipids (Clark et al, 1990), is insensitive for dithiotreitol and has optimal activity at micromolar Ca2+-concentrations (Gronich et al, 1990). cPLA2 also comprises multiple phosphorylation sites, among which a MAP-kinase phosphorylation site (serine-505) that appears to play an important role in enzyme activation (Liscovitch and Cantley, 1994). The 14 kDa PLA2S can be further divided in two groups, based on their amino acid sequence (Heinrikson et al, 1977). Mammalian group I PLA2 comprises the pancreatic type of PLA2 and is characterized by the presence of cys 11. Homologous non-pancreatic group II phospholipase A2 is lacking cys 11. Type II PLA2 is often found as a membrane-bound, enzyme (Aarsman et al, 1989; Ono et al., 1988) which has an optimal activity at millimolar Ca2+-concentrations (Mizushima et al., 1989) and has no selectivity for arachidonic acid (Schalkwijk et al, 1990).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarsman A, de Jong JGM, Arnoldussen E, Neys FW, van Wassenaar PD, van den Bosch H (1989) Immunoaffinity purification, partial sequence and subcellular localization of rat liver phospholipase A2. J Biol Chem 264:10008–10014
Baek SH, Takayoma K, Kudo I, Inoue K, Lee HW, Do JY, Chang MW (1991) Detection and characterization of extracellular phospholipase A2 in pleural effusion of patients with tuberculosis. Life Sci 49:1095–1102
Bonventre JV, Gronich JH, Nemenoff RA (1990) Epidermal growth factor enhances glomerular mesangial cell soluble phospholipase A2 activity. J Biol Chem 265:4934–4938
Clark JD, Lin L-L, Uriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL (1991) A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043–1051
Clark JD, Milona N, Knopf JL (1990) Purification of a 100-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc Natl Acad Sci USA 87:7708–7712
Fishman PH, Curran PK (1992) Brefeldin A inhibits protein synthesis in cultured cells. FEBS Lett 314:371–374
Forst S, Weiss J, Elsbach P, Managanore JM, Reardon I, Heinrikson RL (1986) Structure and functional properties of a phospholipase A2 purified from an inflammatory escudate. Biochemistry 25:8381–8385
Glaser KD, Mobilio D, Chang JY, Senko N (1993) Phospholipase A2 enzymes, regulation and inhibition. Trends Pharmacol Sci 14:92–98
Gronich JH, Bonventre JV, Nemenoff RA (1988) Identification and characterization of a harmonally regulated form of phospholipase A2 in rat renal mesangial cells. J Biol Chem 263:16645–16651
Gronich JH, Bonventre JV, Nemenoff RA (1990) Purification of a high molecular mass form of phospholipase A2 from rat kidney activated at physiological calcium concentrations. Biochem J 271:37–43
Hara S, Kudo I, Chang H, Matsuta K, Miyamoto Y, Inoue K (1989) Purification and characterization of extracellular phospholipase A2 from synovial fluid in rheumatoid arthritis. J Biochem 105:395–399
Hayakawa M, Kudo I, Tomita M, Nojima S, Inoue K (1988) The primary structure of rat platelet phospholipase A2. J Biochem 104:767–772
Heinrikson RL, Krueger ET, Keim DS (1977) Amino acid sequence of phospholipase A2–0C from the venom of cratalus adcimenteus. J Biol Chem 252:4913–4921
Kramer RH, Hession C, Johansen B, Hayes G, McGray P, Pinchang Chow E, Tizard R and Pepinsky RB (1989) Structure and properties of a human non-pancreatic phospholipase A2. J. Biol Chem 264:5768–5775
Kramer RM, Roberts EF, Manetta J, Putman JE (1991) The Ca2+-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem 266:5268–5272
Leslie CC, Voelker DR, Channon JY, Wall MW, Zalarney PT (1988) Properties and purification of an arachidonoyl hydrolyzing phospholipase A2 from a macrophage cell line, Raw 264.7. Biochim Biophys Acta 963:476–492
Lippincott-Schwarz J, Yuan L, Tipper C, Amhardt M, Orci L, Klausner RD (1991) Brefeldin A’s effects on endosomes lysosomes, and TGN suggests a general mechanism for regulating organelle structure and membrane traffic. Cell 67:601–616
Liscovitch M, Cantley LC (1994) Lipid second messengers. Cell 77, 329–334
Mizushima H, Kudo I, Horigomo K, Murakami M, Hayakawa M, Kim DK, Kondo E, Tomita M and Inoue K (1989) Purification of rabbit platelet secretory phospholipase A2 and its characteristics. J Biochem 105:520–525
Ono I, Tojo H, Kuramitsu S, Kagamiyama H, Okamoto M (1988) Purification and characterization of membrane-associated phospholipase A2 from rat spleen. J Biol Chem 263:5732–5738
Pfeilschifter J, Pignat W, Vosbeck K, Márki F (1989a) Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells. Biochem Biophys Res Commun 159:385–394
Pfeilschifter J, Pignat W, Vosbeck U, Márki F, Wiesenberg I (1989b) Susceptibility of interleukin 1- and tumor necrosis factor-induced prostaglandin E2 and phospholipase A2 release from rat renal mesangial cells to different drugs. Biochem Soc Trans 17:916–917
Pfeilschifter J, Schalkwijk C, Briner VA, van den Bosch H (1993) Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 92:2516–2523
Sánchez, R, Vervoordeldonk MJBM, Schalkwijk CG, van den Bosch H (1993) Prevention of the induced synthesis and secretion of group II phospholipase A2 by brefeldin A. FEBS Lett 332:99–104
Schalkwijk CG, Márki F, van den Bosch H (1990) Studieson acyl-chain selectivity of cellular phospholipases A2. Biochem Biophys Acta 1044:139–146
Schalkwijk C, Pfeilschifter J, Márki F, van den Bosch H (1991a) Interleukin-lp, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells. Biochem Biophys Res Commun 174:268–275
Schalkwijk CG, Vervoordeldonk MJBM, Pfeilschifter J, Márki F, van den Bosch H (1991b) Cytokine- and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone. Biochem Biophys Res Commun 180:46–52
Schalkwijk C, Pfeilschifter J, Márki F, van den Bosch H (1992a) Interleukin-lp- and forskolin-induced synthesis and secretion of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-p2. J Biol Chem 267:8846–8851
Schalkwijk CG (1992b) Characterization of cellular phospholipase A2 and their role in prostaglandin E2 formation. Ph.D. thesis, Utrecht University
Seilhamer JJ, Pruzanski W, Vadas P, Plant S, Miller JA, Kloss J, Johnson LK (1988) Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J Biol Chem 264:5335–5338
Sharp JD, White DL, Chiou XG, Goodson T, Gamboa GC, McClure D, Burgett S, Hoskins J, Skatrud PL, Sportsman JR, Becker GW, Kang LH, Roberts EF, Kramer RM (1991)Molecular cloning and expression of human Ca2+-sensitive cytosolic phospholipase A2. J Biol Chem 266:14850–14853
Takayama K, Kudo I, Kim DK, Nagata K, Nozawa Y and Inoue K (1991) Purification and characterization of human platelet phospholipase A2 which preferentially hydrolyzes an arachidonoyl residue. FEBS Lett 282:326–330
Vadas P, Stefanski E, Pruzanski W (1985) Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid. Life Sci 36:579–587
Van den Bosch H (1980) Intracellular phospholipases A. Biochem Biophys Acta 604:191–246
Vervoordeldonk MJBM, Schalkwijk C, Viswanatah BS, Aarsman AJ, van den Bosch H (1994) Levels and localization of group II phospholipase A2 and annexin I in interleukin- and dexamethasone-treated rat mesangial cells: Evidence against annexin mediation of the dexamethasone-induced inhibition of group II phospholipase A2. Biochim Biophys Acta, in press
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Vervoordeldonk, M.J.B.M., Schalkwijk, C.G., Sanchez, R.M., Pfeilschifter, J., van den Bosch, H. (1995). Regulation of 14 kDa Group II PLA2 in Rat Mesangial Cells. In: Packer, L., Wirtz, K.W.A. (eds) Signalling Mechanisms — from Transcription Factors to Oxidative Stress. NATO ASI Series, vol 92. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79675-3_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-79675-3_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79677-7
Online ISBN: 978-3-642-79675-3
eBook Packages: Springer Book Archive